Immune features associated with clinical benefit and adverse events in response to immunotherapy in UC patients
Healy & Sweere et al. Cancer Res (2023)
Poster Highlights
- To identify cell signatures associated with response and irAE development, we used mass cytometry to characterize the immune system in patients with urothelial cancer receiving aPD-1 therapy.
- We found several immune features associated with survival, response to immunotherapy and presentation of adverse events
- While some immune features were only associated with response, others were also associated with irAE.
